Conclusions
The attachment of specific antibody to viral glycoproteins and other structures on the surface of a virus or virus-infected cell has a number of potential consequences to the virus or virus-infected cell. Antibody is multivalent and thus able to redistribute or patch surface viral proteins or virus-encoded structures within the lipid bilayer of the viral envelope or the cell membrane. In certain instances, antibody may agglutinate viruses or virus-infected cells. The physical presence of antibody molecules on the virus surface may interfere with the ability of the virus to infect potentially susceptible cells. Antibody on the surface of virus-infected cells may prevent the maturation and release of virus particles; antibody also can alter certain normal cell functions. The Fc portions of antibody molecules bound to virus-infected cells facilitate interactions with effector cells bearing Fc receptors. In the case of lymphocytes and perhaps phagocytic cells, this interaction may lead to antibody-dependent cellular cytotoxicity (ADCC) [51, 58]. The exposed Fc regions may also facilitate attempts at ingestion by monocytes, macrophages, and polymorphonuclear leukocytes.
Article PDF
Similar content being viewed by others
References
Almeida JD, Waterson AP (1969) The morphology of virus antibody interaction. Adv Virus Res 15: 307
Almeida JD, Cinader B, Howatson A (1963) The structure of antigen-antibody complexes: A study by electron microscopy. J Exp Med 118: 327
Apostolov K, Sawa MI (1976) Enhancement of hemolysis by Newcastle disease virus after pretreatment with heterophil antibody and complement. J Gen Virol 33: 459
Bartholomew RM, Esser AF, Müller-Eberhard HJ (1978) Lysis of oncornaviruses by human serum: Isolation of the viral complement (C1) receptor and identification as p15E. J Exp Med 147: 844
Beebe DP, Cooper NR (1981) Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J Immunol 126: 1562
Beebe DP, Schreiber RD, Cooper NR (1983) Neutralization of influenza virus by normal human sera: Mechanisms involving antibody and complement. J Immunol 130: 1317
Berry DM, Almeida JD (1968) The morphological and biological effects of various antisera on avian infectious bronchitis virus. J Gen Virol 3: 97
Boyse EA, Old LJ, Luell S (1963) Antigenic properties of experimental leukemias. II. Immunological studies in vivo with C57 BL/6 radiation induced leukemias. J Natl Cancer Inst 31: 97
Cooper NR (1979) Humoral immunity to viruses. In: Fraenkel-Conrat H, Wagner R (eds) Comprehensive virology, Vol. 15. Plenum Press, New York, p 123
Cooper NR, Welsh RM (1979) Antibody and complement-dependent viral neutralization. Springer Semin Immunopathol 2: 285
Cooper NR, Jensen FC, Welsh RM, Oldstone MBA (1976) Lysis of RNA tumor viruses by human serum: Direct antibody independent triggering of the classical complement pathway. J Exp Med 144: 970
Daniels C (1975) Mechanisms of virus neutralization. In: Notkins AL (ed) Viral Immunology and Immunopathology. Academic Press, New York, p 79
Daniels CA, Borsos T, Snyderman R, Notkins AL (1969) Neutralization of sensitized virus by the fourth component of complement. Science 165: 508
Daniels CA, Borsos T, Rapp HJ, Snyderman R, Notkins AL (1970) Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci USA 65: 528
Ehrnst A (1977) Complement activation by measles virus cytotoxic antibodies: Alternative pathway C activation by hemagglutination-inhibition antibodies but classical activation by hemolysin antibodies. J Immunol 118: 533
Fearon DT, Austen KF (1977) Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins. J Exp Med 146: 22
Fujinami RS, Oldstone MBA (1980) Alterations in expression of measles virus polypeptides by antibody: Molecular events in antibody induced antigenic modulation. J Immunol 125: 78
Gallagher RE, Schrecker AW, Walter CA, Gallo RC (1978) Oncornavirus lytic activity in the serum of gibbon apes. J Natl Cancer Inst 60: 677
Hicks JT, Klutch MJ, Albrecht P, Frank MM (1976) Analysis of complement-dependent antibodymediated lysis of target cells acutely infected with measles. J Immunol 117: 208
Hirsch RL, Winkelstein JA, Griffin DE (1980) The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus. J Immunol 124: 2507
Joseph BS, Oldstone MBA (1974) Antibody-induced redistribution of measles virus antigens on the cell surafce. J Immunol 113: 1205
Joseph BS, Oldstone MBA (1975) Immunologic injury in measles virus infection. J Exp Med 142: 864
Joseph BS, Cooper NR, Oldstone MBA (1975) Immunologic injury of cultured cells infected with measles virus. J Exp Med 141: 761
Lafferty KJ, Oertelis S (1963) The interaction between virus and antibody. III. Examination of virusantibody complexes with the electron microscope. Virology 21: 91
Lampert PW, Joseph BS, Oldstone MBA (1975) Antibody-induced capping of measles virus antigens on plasma membrane studied by electron microscopy, J Virol 15: 1248
Leddy JP, Simons RE, Douglas RG (1977) Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera. J Immunol 118: 28
Linscott WD, Levinson WE (1969) Complement components required for virus neutralization by early immunoglobulin antibody. Proc Natl Acad Sci USA 64: 520
McConnell I, Lachmann PJ (1976) Complement and cell membranes. Transplant Rev 32: 72
McConnell I, Klein G, Lint TF, Lachmann PJ (1978) Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. Eur J Immunol 8: 453
McSharry JJ, Pickering RJ, Caliguiri LA (1981) Activation of the alternative complement pathway of enveloped viruses containing limited amounts of sialic acid. Virology 114: 507
Mandel B (1979) Interaction of viruses with neutralizing antibodies. In: Fraenkel-Conrat H, Wagner RR (eds) Comprehensive virology, Vol. 15. Plenum Press, New York, p 37
Mayes JT, Nemerow GR, Cooper NR (1983) Alternative complement pathway activation by Epstein-Barr virus infected normal B lymphocytes. Fed Proc 42: 5530
Medicus RG, Götze O, Müller-Eberhard HJ (1976) Alternative pathway of complement: Recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. J Exp Med 144: 1076
Mills BJ, Cooper NR (1978) Antibody independent neutralization of vesicular stomatitis virus by human complement. 1. Complement requirements. J Immunol 121: 1549
Mills BJ, Beebe DP, Cooper NR (1979) Antibody independent neutralization of vesicular stomatitis virus by human complement. J Immunol 123: 2518
Moore FD, Fearon DT, Austen KF (1981) IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b. J Immunol 126: 1805
Nemerow GR, Cooper NR (1981) Isolation of Epstein-Barr virus and studies of its neutralization by human IgG and complement. J Immunol 127: 272
Nemerow GR, Jensen FC, Cooper NR (1982) Neutralization of Epstein-Barr virus by nonimmune human serum: Role of cross-reacting antibody to herpes simplex virus and complement. J Clin Invest 70: 1081
Norley SG, Wardley RC (1982) Complement-mediated lysis of African swine fever virus-infected cells. Immunology 46: 75
Notkins AL, Rosenthal J, Johnson B (1971) Rate zonal centrifugation of herpes simplex virus antibody complexes. Virology 43: 321
Oldstone MBA (1975) Virus neutralization and virus-induced immune complex disease. Prog Med Virol 19: 84
Oldstone MBA, Lampert PW (1979) Antibody-mediated complement-dependent lysis of virusinfected cells. Springer Semin Immunopathol 2: 261
Oldstone MBA, Tishon A (1978) Immunological injury in measles virus infection. IV. Antigenic modulation and abrogation of lymphocyte lysis of virus-infected cells. Clin Immunol Immunopathol 9: 55
Oldstone MBA, Cooper NR, Larson DL (1974) Formation and biologic role of polyoma virus-antibody complexes. J Exp Med 140: 549
Orozlan S, Gilden RV (1970) Immune viral lysis effect of antibody and complement on C type RNA virus. Science 168: 1478
Pangburn MK, Müller-Eberhard HJ (1978) Complement C3 convertase: Cell surface restriction ofβ1H control and generation of restriction on neuraminidase-treated cells. Proc Natl Acad Sci USA 75: 2416
Perrin LH, Oldstone MBA (1977) The formation and fate of virus antigen-antibody complexes. J Immunol 118: 317
Perrin LH, Joseph BS, Cooper NR, Oldstone MBA (1976) Mechanism of injury of virus-infected cells by antiviral antibody and complement: Participation of IgG, F(ab′)2 and the alternative complement pathway. J Exp Med 143: 1027
Poiesz BF, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415
Radwan AI, Crawford TB (1974) The mechanisms of neutralization of sensitized equine arteritis virus by complement components. J Gen Virol 25: 229
Rager-Zisman B, Bloom BR (1974) Immunological destruction of herpes simplex I infected cells. Nature 251: 542
Santoli D, Koprowski H (1979) Mechanisms of activation of human natural killer cells against tumor and virus-infected cells. Immunol Rev 44: 125
Schenkein HA, Ruddy S (1981) The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway. J Immunol 126: 11
Schreiber RD, Müller-Eberhard HJ (1978) Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins. J Exp Med 148: 1722
Schreiber RD, Morrison DC, Podack ER, Müller-Eberhard HJ (1979) Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins. J Exp Med 149: 870
Schreiber RD, Pangburn MK, Medicus RG, Müller-Eberhard HJ (1980) Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement. Clin Immunol Immunopathol 15: 384
Sherwin SA, Benveniste RE, Todaro GJ (1978) Complement-mediated lysis of type C virus: Effective primate and human serum on various retroviruses. Int J Cancer 21: 6
Sissons JGP, Oldstone MBA (1980) Antibody-mediated destruction of virus-infected cells. Adv Immunol 29: 209
Sissons JGP, Cooper NR, Oldstone MBA (1979) Alternative complement pathway-mediated lysis of measles virus infected cells: Induction by IgG antibody bound to individual glycoproteins and comparative efficacy of F(ab′)2 and Fab′ fragments. J Immunol 123: 2144
Sissons JGP, Schreiber RD, Perrin LH, Cooper NR, Müller-Eberhard HJ, Oldstone MBA (1979) Lysis of measles virus infected cells by the purified cytolytic alternative complement pathway and antibody. J Exp Med 150: 445
Sissons JGP, Oldstone MBA, Schreiber RD (1980) Antibody-independent activation of the alternative complement pathway by measles virus infected cells. Proc Natl Acad Sci USA 77: 559
Stollar V (1975) Immune lysis of Sindbis virus. Virology 66: 620
Theofilopoulos AN, Perrin LH (1977) Lysis of human cultured lymphoblastoid cells by cell induced activation of the properdin pathway. Science 195: 878
Wallis C, Melnick JL (1971) Herpes virus neutralization: The role of complement. J Immunol 107: 1235
Welsh RM (1977) Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement. J Immunol 118: 348
Welsh RM (1978) Mouse natural killer cells: Induction, specificity, and function. J Immunol 121: 1631
Welsh RM, Cooper NR, Jensen FC, Oldstone MBA (1975) Human serum lyses RNA tumor viruses. Nature 257: 612
Welsh RM, Cooper NR, Jensen FC, Oldstone MBA (1976) Inactivation and lysis of oncornaviruses by human serum. Virology 74: 432
Welsh RM, Lampert PW, Burner PA, Oldstone MBA (1976) Antibody complement interactions with purified lymphocytic choriomeningitis virus. Virology 73: 59
Zinkernagel RM, Doherty PC (1979) MHC-restricted cytotoxic T cells: Studies on the biological role of polymorphic major transplantation antigens determining T cell restriction-specificity, function, and responsiveness. Adv Immunol 27: 52
Author information
Authors and Affiliations
Additional information
Publication # :3110-IMM. Supported by NIH grants CA14692 and AI17354
Rights and permissions
About this article
Cite this article
Cooper, N.R., Nemerow, G.R. Complement, viruses, and virus-infected cells. Springer Semin Immunopathol 6, 327–347 (1983). https://doi.org/10.1007/BF02116278
Issue Date:
DOI: https://doi.org/10.1007/BF02116278